Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Characterization of an Acyclovir-Resistant Herpes Simplex Virus Type 2 Strain Isolated from a Premature Neonate

Ronda J. Oram, Daniel Marcellino, Daniel Strauss, Erik Gustafson, Christine L. Talarico, Adrienne K. Root, Prem L. Sharma, Ken Thompson, Joyce D. Fingeroth, Clyde Crumpacker and Betsy C. Herold
The Journal of Infectious Diseases
Vol. 181, No. 4 (Apr., 2000), pp. 1458-1461
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30109163
Page Count: 4
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Characterization of an Acyclovir-Resistant Herpes Simplex Virus Type 2 Strain Isolated from a Premature Neonate
Preview not available

Abstract

Acyclovir resistance is not a recognized problem among neonates with perinatal herpes simplex virus (HSV) infection. A premature newborn with neurocutaneous HSV infection was treated for 21 days with acyclovir. Disseminated disease recurred 8 days later. A recurrent isolate was resistant to acyclovir and lacked thymidine kinase activity on the basis of a frameshift mutation in the thymidine kinase (tk) gene. Compared with the sensitive isolate obtained during primary infection, replication of the resistant isolate was reduced on primary and permanent cells and even further impaired on cells deleted for cellular tk. The resistant isolate lacked virulence in a murine model of genital infection. Acyclovir-resistant HSV-2 mutants can develop rapidly in neonatal infection and cause clinically significant disease, despite decreased replication in vitro and attenuated virulence in an animal model.

Page Thumbnails

  • Thumbnail: Page 
1458
    1458
  • Thumbnail: Page 
1459
    1459
  • Thumbnail: Page 
1460
    1460
  • Thumbnail: Page 
1461
    1461